Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
PharmTech
October 31, 2019
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

In this issue:

Mylan Recalls Alprazolam Tablets

Gerresheimer Renovates Glass Production Facility

First Ebola Vaccine Gains Conditional Marketing Authorization Recommendation


Top Stories

Sartorius Acquires Danaher Life Science
Businesses for $750 million

The transaction is set to be completed in the first quarter of 2020.
/ read more /


GSK Divests Vaccines to Bavarian Nordic for up to $1.1 Billion

The transaction is anticipated to close by the end of 2019.
/ read more /

advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe


advertisement

PYRAMID Laboratories, Inc. is a CMO focused on injectables, established in 1988 in Southern California, we offer aseptic vial and syringe filling, as well as lyophilization, for both Clinical and Commercial products. Our laboratory offers development and analytical capabilities in a cGMP/GLP setting. For 30 years, we have provided clients with Top Quality services assuring that their critically important parenteral products reach patients in need.
Learn More


Industry News

Mylan Recalls Alprazolam Tablets

The company is recalling Alprazolam Tablets, USP C-IV 0.5 mg because of potential presence of foreign substance.
/ read more /


NIH and Bill & Melinda Gates Foundation to
Invest $200 Million into Sickle Cell Disease and HIV Gene-Based Cures

The goal of the investment is for the cures to be made available across the globe, including in sub-Saharan Africa’s low-resource communities.
/ read more /


More Industry News

Supplier News

Gerresheimer Renovates Glass
Production Facility

Gerresheimer enlarged a cleanroom, installed a high-performance furnace, and automated testing and packaging systems for pharmaceutical glass packaging in Essen, Germany.
/ read more /


GE Healthcare Launches Viral Vector-Based Gene Therapy Manufacturing

GE Healthcare Life Sciences’ KUBio box is an integrated, flexible biomanufacturing environment for viral vector-based gene therapies.
/ read more /


More Supplier News
advertisement
advertisement
advertisement
advertisement
advertisement
advertisement

Attending CPhI Worldwide? Don’t Miss Out!
The increasing use of and interest in innovative combination products – products combining a drug & device – is raising significant challenges both for regulators and the industries they regulate. Join Nelson Labs Speaker Lise Vanderkelen, PhD during her ICSE Theater presentation at CPhI Worldwide on 6 November from 16:30-17:00.
Visit the Nelson Labs website for more information.

Bio/Pharma News

Takeda Acquires Global License for Celiac Disease Therapy for $420 million

The therapy received positive results in a randomized, double-blind, placebo-controlled clinical trial in 34 adults with proven celiac disease.
/ read more /


First Ebola Vaccine Gains Conditional
Marketing Authorization Recommendation

CHMP has recommended that Ervebo (rVSVΔG-ZEBOV-GP), a vaccine for active immunization against Ebola, be granted conditional marketing authorization in the EU.
/ read more /

More Bio/Pharma News

Regulatory News

FDA Gives Update on Actions to Address Opioid Crisis

The agency’s implementation of the SUPPORT Act has included new guidance documents and actions to restrict illicit drugs entering the US.
/ read more /


CHMP Recommends EU Marketing
Authorization for Baqsimi

CHMP has recommended that Baqsimi (glucagon), a non-injectable treatment for severe hypoglycemia, be granted marketing authorization in the EU.
/ read more /


More Regulatory News

advertisement

FEATURED TOPICS

ANALYTICS

Distribution of Data: The Central Limit Theorem

Using the central limit theorem concerning the distribution of means allows one to justify the assumption of the normal distribution.
/ read more /

QUALITY SYSTEMS

ALCOA+ and Data Integrity

Data supporting the quality and safety of product must meet the ALCOA+ elements in order to avoid regulatory citations for data integrity issues, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
/ read more /


advertisement

Explore Transparency with the Emprove® Program
With the Emprove® Program, full supplier transparency is available at your fingertips. Access regulatory information online through our Emprove® Suite. Find comprehensive regulatory documentation for filters, single-use components and raw and starting materials to simplify your qualification, risk assessment, and process optimization.
Learn More


FORMULATION

Formulation and Development
Considerations for Biologics

A complete understanding of primary packaging physicochemical properties is necessary in the formulation and development of biologics.
/ read more /

REGULATORY WATCH

Out with the Old and In with the New
European Commission

A new European Commission is likely, with the support of a new European Parliament, to give a higher profile to healthcare and pharmaceutical matters during its five years in office.
/ read more /


UPCOMING WEBCASTS


An Integrated Approach to Spray Drying: From Scale-Up to Manufacturing
November 19, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now


Replacing Settle Plates with Active Air Sampling
Wednesday, November 13, 2019 at 10am EST | 9am CST | 3pm GMT | 4pm CET
Register Now


How to Approach Preparative LC for Compound Purification in the Research and Development Laboratory
Thursday, November 7, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now


Choosing The Right CDMO For Late-Phase Clinical Trials
Wednesday, October 30, 2019 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Register Now


New Research Revealed on a Promising Functional Alternative to Surfactants within Biologic Formulations
Tuesday October 29, 2019 at 10am EDT | 9am CDT | 2pm GMT | 3pm CET
Register Now


Data Integrity and the Next Level of Connectivity in a Modern Lab
Tuesday, October 29, 2019 at 11am EDT | 8am PDT| 3pm GMT| 4pm CET
Register Now


ON DEMAND WEBCASTS

A Roadmap for Early Development to Commercial Manufacturing
On Demand
Learn More


An Integrated Approach to Rapidly Delivering Bioavailability-Challenged Small Molecules to the Clinic
On Demand
Learn More


New Draft USP <922> Chapter for Water Activity Measurement
On Demand
Learn More


Workflow Breakthroughs that Are Improving Data Quality and Efficiency and Changing Pharmaceutical Analysis
On Demand
Learn More



Events

AAPS PharmSci 360

November 3–6, 2019

CPhI Worldwide

November 5–7, 2019

Outsourcing & Supply Chain–A 360° View

November 12–13, 2019


more events

eBOOKS

Biologics and Sterile Drug Manufacturing 2019

The editors explore novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.


contribute | contact editors | CONTACT SALES | subscribe | advertise